{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:23:27Z","timestamp":1740137007565,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.gastrohep.2024.02.003","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T05:12:09Z","timestamp":1707801129000},"page":"605-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perfil cl\u00ednico de los pacientes espa\u00f1oles con hepatitis C na\u00efve con cirrosis compensada tratados en el estudio CREST"],"prefix":"10.1016","volume":"47","author":[{"given":"Francisco","family":"Jorquera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Ahumada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Castiella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Mari\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Castellote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Uriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2024.02.003_bib0135","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/liv.14779","article-title":"Progress towards hepatitisC virus elimination in high-income countries: An updated analysis","volume":"41","author":"Gamkrelidze","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0140","unstructured":"Secretar\u00eda General de Sanidad. Ministerio de Sanidad. Plan Estrat\u00e9gico para el Abordaje de la HepatitisC en el Sistema Nacional de Salud (PEAHC) [consultado 4 May 2023]. Disponible en: https:\/\/www.sanidad.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/hepatitisC\/PlanEstrategicoHEPATITISC\/home.htm"},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0145","first-page":"5","article-title":"Advances in the treatment of hepatitisC virus infection","volume":"20","author":"Thomas","year":"2012","journal-title":"Top Antivir Med."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0150","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.3748\/wjg.v18.i42.6060","article-title":"Current progress in the treatment of chronic hepatitis C","volume":"18","author":"Alexopoulou","year":"2012","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0155","unstructured":"Ficha t\u00e9cnica Maviret 100mg\/40mg comprimidos recubiertos con pel\u00edcula. Aemps.es. Disponible en: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1171213001\/FT_1171213001.html."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0160","unstructured":"Ficha t\u00e9cnica Epclusa 400mg\/100mg comprimidos recubiertos con pel\u00edcula. Aemps.es. Disponible en: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1161116001\/FT_1161116001.html"},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0165","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.cgh.2020.06.044","article-title":"Eight weeks of treatment with glecaprevir\/pibrentasvir is safe and efficacious in an integrated analysis of treatment-na\u00efve patients with hepatitisC virus infection","volume":"18","author":"Zuckerman","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.gastrohep.2021.05.015","article-title":"Non-pharmacologic direct cost of a simplified strategy with glecaprevir\/pibrentasvir for 8weeks in na\u00efve non-cirrhotic patients with hepatitisC implemented in clinical practice. The Just SIMPLE Study","volume":"45","author":"Turnes","year":"2022","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0175","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jhep.2019.10.020","article-title":"Glecaprevir\/pibrentasvir for 8weeks in treatment-na\u00efve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial","volume":"72","author":"Brown","year":"2020","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0180","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitisC: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17425255.2018.1472236","article-title":"An update on the toxicological considerations for protease inhibitors used for hepatitisC infection","volume":"14","author":"Mak","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0190","doi-asserted-by":"crossref","first-page":"24133","DOI":"10.1038\/s41598-021-01885-0","article-title":"Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: A 2-year registry review","volume":"11","author":"Picchio","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0195","unstructured":"Secretar\u00eda de Estado de Sanidad, Ministerio de Sanidad 2022 Estudio de monitorizaci\u00f3n efectividad terap\u00e9utica (SITHepaC) [consultado 4 May 2023]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/farmacia\/pdf\/Registro_SITHEPAC_11_05_2022.pdf"},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0200","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1007\/s12325-022-02158-6","article-title":"Safety and effectiveness using 8 weeks of glecaprevir\/pibrentasvir in HCV-infected treatment-na\u00efve patients with compensated cirrhosis: The CREST study","volume":"39","author":"Cornberg","year":"2022","journal-title":"Adv Ther."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: Protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0210","first-page":"175","article-title":"HepatitisC diagnosis slowdown in high-prevalence groups and using decentralised diagnostic strategies during the COVID-19 pandemic","volume":"115","author":"Morales-Arr\u00e1ez","year":"2023","journal-title":"Rev Esp Enferm Dig."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0215","doi-asserted-by":"crossref","first-page":"880435","DOI":"10.3389\/fpubh.2022.880435","article-title":"The negative impact of COVID-19 in HCV HIV, and HPV surveillance programs during the different pandemic waves","volume":"10","author":"Romero-Hern\u00e1ndez","year":"2022","journal-title":"Front Public Health."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0225","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s12325-020-01301-5","article-title":"Effectiveness of 8-week glecaprevir\/pibrentasvir for treatment-na\u00efve compensated cirrhotic patients with chronic hepatitisC infection","volume":"37","author":"Flamm","year":"2020","journal-title":"Adv Ther."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0265","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/liv.14937","article-title":"Glecaprevir\/pibrentasvir for 8weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German HepatitisC-Registry","volume":"41","author":"Klinker","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0235","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s40121-021-00455-1","article-title":"Real-world outcomes in historically underserved patients with chronic hepatitisC infection treated with glecaprevir\/pibrentasvir","volume":"10","author":"Aghemo","year":"2021","journal-title":"Infect Dis Ther."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0240","unstructured":"Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado, Sociedad Espa\u00f1ola de Patolog\u00eda Digestiva, y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Diagn\u00f3stico de la hepatitis C en un solo paso. Disponible en: https:\/\/seimc.org\/contenidos\/gruposdeestudio\/gehep\/dcientificos\/documentos\/gehep-dc-2018-Diagnostico_en_un_paso_HepatitisC.pdf"},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eimc.2020.03.004","article-title":"HepatitisC reflex testing in Spain in 2019: A story of success","volume":"39","author":"Crespo","year":"2021","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0250","unstructured":"World Health Organization (WHO). Updated recommendations on simplified service delivery and diagnostics for hepatitisC infection. Policy Brief. Geneva: World Health Organization; 2022 [consultado 4 May 2023]. Disponible en: https:\/\/www.who.int\/"},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0255","first-page":"529","article-title":"HepatitisC in homeless people: Reaching a hard-to-reach population","volume":"113","author":"Alfranca","year":"2021","journal-title":"Rev Esp Enferm Dig."},{"key":"10.1016\/j.gastrohep.2024.02.003_bib0260","first-page":"7","article-title":"Review of hepatitisC screening programs for immigrants in Spain from endemic countries","volume":"113","author":"Alarc\u00f3n Linares","year":"2021","journal-title":"Rev Esp Enferm Dig."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570524000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570524000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T22:42:01Z","timestamp":1715726521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570524000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0210570524000372"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2024.02.003","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perfil cl\u00ednico de los pacientes espa\u00f1oles con hepatitisC na\u00efve con cirrosis compensada tratados en el estudio CREST","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2024.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}